HDAC3 and cancer: Since HDAC3 can trigger cancer proliferation, metastasis, and angiogenesis [42] and c-Myc is a well-known pro-tumorigenic molecule, the relationship between HDAC3, c-Myc, and B7-H6 is of particular clinical interest.